• 1. Conformational behaviour of medium-sized rings. Part 10. Dithiosalicylides and trithiosalicylides
  G. Bruce Guise,W. David Ollis,Judith A. Peacock,Julia Stephanidou Stephanatou,J. Fraser Stoddart J. Chem. Soc. Perkin Trans. 1 1982 1637
• 2. Electroorganic reactions. Part 55.Quinodimethane chemistry. Part 3. Transition metal complexes as inter- and intra-molecular redox catalysts for the electrosynthesis of poly(p-xylylene) (PPX) polymers and oligomers
  Robert G. Janssen,James H. P. Utley,Emmanuelle Carré,Evelyne Simon,Heike Schirmer J. Chem. Soc. Perkin Trans. 2 2001 1573

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Aminobenzoic acids and derivatives

Recent Advances in the Study of 2-Amino-3,6-dimethylbenzoic Acid (CAS: 15540-91-7)

2-Amino-3,6-dimethylbenzoic acid (CAS: 15540-91-7) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug development, particularly as a building block for novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic uses.

One of the key areas of investigation has been the synthesis and optimization of 2-amino-3,6-dimethylbenzoic acid. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an improved synthetic route that enhances yield and purity, making it more viable for large-scale production. The researchers utilized a combination of catalytic hydrogenation and selective methylation to achieve a 90% yield, significantly higher than previous methods. This advancement is critical for ensuring a stable supply of the compound for further pharmacological studies.

In terms of biological activity, recent research has highlighted the compound's potential as a precursor for anti-inflammatory and anticancer agents. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of 2-amino-3,6-dimethylbenzoic acid exhibited potent inhibitory effects on cyclooxygenase-2 (COX-2), an enzyme implicated in inflammatory processes. The study identified specific structural modifications that enhance selectivity for COX-2 over COX-1, reducing the risk of gastrointestinal side effects commonly associated with nonsteroidal anti-inflammatory drugs (NSAIDs).

Another promising avenue of research involves the use of 2-amino-3,6-dimethylbenzoic acid in the development of kinase inhibitors. A preprint article from early 2024 described the synthesis of a series of small-molecule inhibitors targeting the epidermal growth factor receptor (EGFR), a key player in cancer cell proliferation. The lead compound, derived from 2-amino-3,6-dimethylbenzoic acid, showed nanomolar potency against EGFR-mutant non-small cell lung cancer (NSCLC) cell lines. These findings suggest potential applications in precision oncology, particularly for patients with resistant mutations.

Despite these advancements, challenges remain in optimizing the pharmacokinetic properties of 2-amino-3,6-dimethylbenzoic acid derivatives. A recent review in Drug Discovery Today (2024) emphasized the need for further studies on bioavailability and metabolic stability. Researchers are exploring prodrug strategies and formulation technologies to address these limitations, with preliminary results indicating improved oral absorption in animal models.

In conclusion, 2-amino-3,6-dimethylbenzoic acid (CAS: 15540-91-7) continues to be a valuable scaffold in medicinal chemistry, with recent studies uncovering its potential in inflammation and cancer therapy. Ongoing research aims to refine its synthetic accessibility and optimize its pharmacological profile, paving the way for future clinical applications. The compound's versatility and the growing body of evidence supporting its therapeutic potential make it a promising candidate for further investigation.

• 4389-50-8(2-Amino-6-methylbenzoic acid)
• 90259-29-3(Benzoic acid, 2-amino-6-methyl-, hydrochloride)
• 61837-54-5(1,2,4-Benzenetricarboxylic acid, 5-amino-)
• 15089-51-7(2-Amino-4,5-dimethylbenzoic acid)
• 5434-20-8(3-Aminophthalic acid)
• 88744-60-9(Benzenemethanol, 2,4,6-trimethyl-, 2-aminobenzoate)
• 6946-22-1(3-Aminophthalic acid hydrochloride)
• 62351-68-2(1,2-Benzenedicarboxylic acid, 3,5-diamino-)
• 769908-43-2(1,2-Benzenedicarboxylicacid, 3-amino-4-methyl-)
• 24587-05-1(5-Amino-2,4-dimethylbenzoic acid)